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We have two goals in this paper: first, to provide a diagnosis of global health and underline some of its blockages; 
second, to offer an alternative interpretation of what the demands for those in global health may be. The assumption 
that health is a good that requires no further explanation, and that per se it can serve as an actual modus operandi, 
lays the foundations of the problem. Related blockages ensue and are described using HIV prevention with a focus 
on vaginal microbicides as a case study. Taking health as a self-evident, and self-explanatory “good” limits other 
possible goods; and prevents inquiry into the actual practices of creating good. We propose that to create conditions 
under which global health could be reconstructed, problematization be taken up as a practice, around a series of 
questions asked in conjunction with those ever-urgent ones of how to ameliorate the condition of living beings. 
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Accepting Weber’s mandate, in this article, we have two aims. One is to provide a preliminary diagnosis of 
the structure of the field of global health and some of its blockages as we see them. The other is to offer an 
alternative interpretation of what “the demands of the day” may be for researchers, workers and professionals in 
global health.  What counts as “global health”, meaning, what is included and excluded, is contested. Obviously not 
wholly new, global health is often placed in a lineage following tropical medicine and international health.
4
 
Tropical medicine developed out of centuries of colonialism, but was founded as a discipline and 
institutionalized at the turn of the twentieth century.
5
 Originally characterized by a focus on vector-borne diseases, 
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In the early years of the 1900s, “sanitation” and “hygiene”, as well as the control of infectious diseases across 
borders, were becoming international efforts.
7
 These developed into the field of international health, which 
diversified and gained stature as a term around the middle of the twentieth century, especially with the creation of 
the World Health Organization (WHO). International health in the past encompassed much of what is presented as 
global health today: dramatic disease eradication campaigns – famously malaria, which failed and smallpox, which 
succeeded–and general public health writ large. Plans often linked socioeconomic development and health, and 
included international programs for education and training, family planning and immunizations.
8
 
The World Health Organization’s mid-1950s malaria program was actually one of the first initiatives to be 
labeled “global”. Drawing from the conceptualization of the “global population problem” that gained strength in the 
1970s, as well as the environmental movement’s discourses around the threat of “global warming”, by the mid-
1990s, with AIDS a full-blown pandemic, the idea of global health threats had proliferated. In tandem, the WHO, 
which was struggling politically and bureaucratically to define itself against the World Bank’s encroachment via 
health financing, saw the utility in branding global health as a distinct field.
9
 The US Center for Disease Control 
began using the term “global infectious disease threats” in 1995;
10
 soon after, the first Institute of Global Health was 
established at the University of California, San Francisco in 1999.  
“Global health” includes, at least: people and populations in pursuit of health around the globe; and an 
assemblage of governmental and nongovernmental organizations, university departments, health, academic and 
policy professionals; and the political, social, economic and ethical relations within and between them. All these 
stakeholders are invested in distinct strategies towards specific objectives; their priorities and needs will come into 
conflict. Yet in global health, the moral terrain is already presumed to be known: health is a good, the content of 
which need only be determined by various technical verifications. The ethics of research trials are taken up as a 
question of working out details such as ascertaining the standard of care, and deciding if this can be provided. The 
use of health as a “good”, which, implicitly, requires no further explanation, and, rather impracticably, can serve as 
an actual guide in action, presents us with a problem. At least, figuring out what kinds of goods health may be, and 
by what micropractices they are actualized, requires further work. Dedication to “saving lives by improving 
health”
11
 is properly aspirational: the task is then how to provide that aspiration with adequate equipment.
12
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In global health the imperative to act seems all too obvious, and the vocational veneer unassailable. The 
demands of the day are generally formulated along these lines: too many people’s lives are diminished due to illness, 
or they are dying; they have a right to health; the situation is urgent and hence we must act. This brooks no argument 
because health is taken to be self-explanatory and a good, thereby the amelioration of health constitutes ethical 
practice. In part because of the expansive justificatory power of health in this narrative, the field of global health 
attracts and comprises not only people from policy and medical sciences, but also from disciplines such as 
economics, agriculture, veterinary medicine, and environmental science.
13
 Health as a focus bestows the mantle of a 
shared vocation on these normally disparate spheres of professional activity, and value.  
Two medical anthropologists ably covered this terrain in a 2009 review.
14
 They position anthropological work 
on global health as the disciplinary progeny of critical medical anthropology, which focuses on the socio-structural 
causes of disease. If babies of poor parents are dying from diarrhea, goes a paradigmatic example, this may be 
because of a political or economic system that fails to provide clean water for all. “The ultimate goal,” wrote the 
authors, “is to reduce global health inequities and contribute to the development of sustainable and salutogenic, 
sociocultural, political, and economic systems”. They admonish in conclusion: 
 
the problems living beings face globally are too vast and the assaults on social justice and the environment too egregious for us to 
worry overly much about the sullying effects of doing applied work…being a principled “public intellectual” is sometimes not 
enough. We are called to apply our tools and knowledge, to seek interdisciplinary and intersectoral partnerships, and to both 




Their argument is congruent with those of global health advocates. The acclaimed “Treatment Action 
Campaign” (TAC) was founded in 1998 in South Africa to advocate for “A unified quality health care system which 
provides equal access to HIV prevention and treatment services for all people”.
16
 The Treatment Action Campaign 
says that it will achieve its mission “to inform and support national advocacy efforts through its branches, providing 
a platform for people to mobilize and organize around HIV and related health rights”. Struggling against the “assault 
on social justice” embodied in the obstacles faced by HIV positive people in getting access to antiretroviral therapies 
is clearly included among “the demands of the day”. The call to apply tools and knowledge is likewise vocational: 
the question we ask is, how?  
We argue that the fairly common dictate to “propose and engage directly in potential solutions” tends to skip a 
step, and an opportunity, for scholarly work. In fact, there need first be a refusal of first-order questions and 
demands in order to open a space for inquiry.
17
There are multiple rationales at work in a problem-space which are 
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not self-evident, nor necessarily equally adequate to the formulation of the situation and ways to deal with it. Quite 
pragmatically, assuming that the problem is, say, health disparities, and absorbing that problem into the even more 
general categories of poverty and structural violence, may not provide sufficient analytical purchase. Potts et al. 
note,
18
for example:  
 
The presumption…that poverty increases vulnerability to HIV infection is challenged by studies such as an analysis of recent 
Demographic and Health Surveys (DHSs) from Africa, which shows a strong positive correlation between HIV prevalence and 
wealth in eight countries examined…Among Kenyan women, HIV prevalence is 3.9% in the lowest economic quintile and 12% in 
the highest. 
 
Doing “applied work” too often indicates taking on the problems of one’s subjects – which in the case of this 
paper are those who work in global health – as one’s own. We suggest that doing so is not, in fact, an act of 
partnership towards a goal of mutual flourishing, of which “health” is surely one part. One role of inquiry is to 
produce the intellectual tools to reconstruct a situation.
19
 A pressing task for scholars consists in posing questions 
about the problems as posed. In this spirit, what we propose here is a brief critique of some of the ways in which 
“goods” in global health function both to animate and to block practice. This is critique in the sense of trying to 
bring to light the limitations of thinking, acting and relating. Which is to say, health as a good is only problematic to 
the extent that we overestimate its ability to indicate right practices.  
Advocacy, in meaning and in practice, is fighting for a cause. The rightness of that cause has already been 
decided. While the approach is almost certainly coherent within a given line of reasoning and valuation, the metric is 
not necessarily the same as, to give only one illustration, that applied from the perspective of the public health needs 
of a population. Those who work on garnering funding, either for scientific research into a given approach to disease 
or to raise awareness and form public opinion, have often championed a specific approach in which they are 
invested. One example is the development of HIV prevention strategies that women can control and use 
independently of a sexual partner who is unwilling to use protective measures. Pointedly, who can argue against 
this? Women should have options and the opportunity to choose between them. Yet, while the best vaginal 
microbicide gels up to now have shown 54% effectiveness in the highest adherers,
20
 male circumcision has a 60% 
effect on the reduction of HIV transmission
21
 and, as one article dryly observed, adherence is not much of a 
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 Debate over how support should be allocated between vaginal microbicides, male circumcision, and 
other HIV prevention interventions is reasonable and necessary: we point to that debate as a place wherein there is a 
role for thought about the conceptualization of the problem, and how solutions are implemented. Decisions have to 
be made about research and funding agendas; here is a situation in which to apply the test of reality: what is the 
good sought? What are the practices by which it will be created? 
This brings us to a paired blockage. If the scholar believes that his or her position is to throw one’s lot in with 
the solutions advocated, there is one, an acceptance that the correct problem has been identified, as well as, two, 
adoption of that specific solution. It is our opinion that neither can be accepted per se. If what should be done is 
always already assumed to be known, and the request made to researchers is simply how to do something, there is no 
possibility of asking different questions, and reaching different answers. There are reasons, then, to refuse the first-
order demand for answers, not only despite their urgency but because of it. The list of urgent needs provided as the 
rationale for the call for action, many of which have remained unchanged throughout the history of public health, 
serves equally to indicate that the way some problems have been formulated and approached has not meet even 
internally defined goals. 
II  Case Study: HIV Prevention. 
A significant part of global health efforts are oriented around the simple formulation: disease and health 
disparities should be addressed by advances in biomedical technologies. This is also an oft-knocked straw man, as it 
seems to postulate an adequate health care system into which a new technology could be integrated, an ideal so far 
from reality that even the technophilic dismiss it. Chris Elias, the president of PATH (as the Program for 
Appropriate Technology in Health is called) said,  
 
The most unproductive debate in global health is whether we should work on technologies or systems…you have to do it all, in an 
integrated way. The technology has to be designed for the system, for people who are undertrained, for inadequacies. You have to 
design the technologies for the system that is going to use it, as well as get behavior change in the providers and those treated.23 
 
Despite dismissal of the technology/heath systems opposition, constructing or reconstructing health care 
systems–some still struggling from cuts enacted under the Washington Consensus
24
–would require a massive input 
of resources, most of which are set to go towards inarguably important technological fixes, from prophylactic 
antiretroviral HIV pills to new antigens for vaccine-preventable diseases. The agreed upon good of “health” has not 
yet been rendered into consensus about how to achieve it. Instead, there is a history of well-rehearsed debates about 
how health can be put into practice and produced through projects.  
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Many resources are used on "vertical" interventions such as the HIV treatment programs that the U.S. 
President's Emergency Plan for AIDS Relief (PEPFAR)
25
 tends to fund, or polio eradication campaigns
26
 and, in a 
zero-sum game, this means less money and effort can potentially be spent on other health sectors, such as primary 
care.
27
 A growing emphasis on "integrated care", a dusted-off version of an earlier World Health Organization 
precept,
28
 can be seen as an attempt to refuse the zero-sum formulation. The Mexican “diagonal approach”
29
 for 
example, combines vertical interventions selected to address priority primary health care needs,
30
 through which the 
"horizontal" health care system is at least partially strengthened. But resources also have to be coordinated in such a 
way as to coherently address the problems besetting a national population.
31
 Even the best solution in a narrow sense 
can backfire in the context of the whole. Aid money funneled through NGOs can strengthen those NGOs, for 
instance, rather than strengthening a basic health care system, and can also pull valuable human skill towards those 
efforts, and hence away from others.
32
 
Not all the stumbling blocks that have appeared along the path of the technical amelioration of global health 
can be ascribed to divergent philosophies about the allocation of resources however. The history of the development 
of anti-HIV vaginal microbicide gels, including the design of randomized controlled trials, serves here as a study of 
other types of problems.  
Microbicides are chemical agents that can be used intravaginally with the goal of protecting users against 
sexually transmitted infections, including HIV.
33
 As women now account for 60% of the 22.5 million infected 
subjects in sub-Saharan Africa,
34
 a vaginal microbicide that could empower women against HIV infection has much 
potential for use. The first-generation of microbicidal gels were detergents, which contain polyanion compounds 
that, unfortunately, “have limited potency in vitro, particularly against the most commonly transmitted strains of 
HIV-1”;
35
 two of the gels compromised the integrity of the genital tract, increased inflammation and interfered with 
immune function.
36
 The efficacy trials of these products produced, in the muted language of the genre, disappointing 
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 The first six candidates showed no effect on decreasing HIV transmission, and those two that produced 
“epithelial barrier disruption” actually showed a trend towards increasing risk of infection.
38
 
Another reason for the early candidates’ “disappointing results” could be that semen decreases the 
effectiveness of these microbicides by enhancing the virus with amyloid-like aggregates called ‘semen-derived 
enhancer of viral infection’ (SEVI).
39
 To repeat one of the droller lines in the microbicide literature, “The 
identification of microbicides that are active in the presence of semen/SEVI would be a positive step towards the 
development of effective products.”
40
 
What happened such that these products were chosen, and so many trials carried out competitively? This could 
be chalked up as unavoidable dead-ends along the road to progress, but we think rather that there was a lack of 
attention to the good at stake, and to the question of if the being actions taken would produce the desired good. 
Grant et al. point out, “observations of polyanion-mediated enhancement of such viruses, both in vitro and in vivo, 
were made 15 to 20 years ago”.
41
 That subsequent testing of the polyanions was conducted on thousands of women, 
they go on, “raises concerns about the preclinical research that was performed on these microbicide candidates”.
42
 
Grant suggests that, on one side, there was pressure to fast-track something, and “multiple funding agencies or 
institutions each felt the need to adopt its own polyanion candidate”.
43
 The products were thought to be generally 
safe – despite early tests of nonoxynol-9 which showed inflammation – but inhibiting sexual transmission of HIV 
turned out to be much harder than originally thought.  
We shift to a different type of explanation for the dismal track record of these trials, as well as those of other 
interventions, namely, “poor adherence”: participants did not always use the product, or, when they did, it wasn’t 
always used quite right. This can be due in part to lack of attention to the biophysical properties – consistency and 
formulation, for example – of microbicide gel vehicles on the part of researchers, an evocative indicator of the need 
for “interdisciplinary and intersectoral partnerships”.
44
 
To understand this particular issue, one can think of sunscreen. To prevent sunburn, sunscreen must be 
adequately distributed onto the skin’s vulnerable locations. This requires the appropriate deployment of the 
sunscreen, which depends on both biophysical aspects of the potion – its wateriness for instance - and the coating 
mechanism – the manner in which the hand coats the skin. The same rationale applies for the delivery of a 
microbicide gel onto the vaginal epithelium. In order to work effectively, the microbicide’s active ingredients must 
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be appropriately distributed in order to target tissue sites where HIV transmission occurs.
45
 Importantly, this has 
implications in terms of the gel’s design and the application instructions that should be given to participants of 
clinical trials.  
There is a wait time between the application of a microbicide gel and maximally safe sex. A gel that is highly 
viscous - say as viscous as honey - may require several hours to spread effectively; a less viscous, watery gel may 
require only a few minutes.
46
 The gel’s viscosity dictates texture and governs flow; it is one of several physical 
attributes that link a user’s preference and physical functionality. A thick gel might be preferred to a thin gel, which 
is potentially messy. But, the desirability of a longer wait time will depend on the user’s situation and personal 
preferences.
47
 The biophysical and behavioral attributes of microbicide gels are intrinsically linked: the gel first 
must be physically realistic (a very thick gel is never going to spread very fast), then acceptable to the user, and 
finally applied in a way promoting timely, effective coating.  
This might seem to belabor the point, since clearly, putting gel formulation considerations and user preference 
together in designing trials would facilitate greater user adherence, enhance effectiveness and produce better results. 
Yet, clinical trials quite often did not take into account such considerations, in particular in the application 
instructions given to participants. The CAPRISA 004 trial reduced the incidence of HIV infection, a success on the 
path to a microbide gel product.
48
 In the trial, women were instructed to insert one dose of gel within 12 hours 
before sex and a second dose of gel as soon as possible within 12 hours after sex, modeled on the timing of another 
medication that prevented mother-to-child HIV transmission.
49
 The gel vehicle used in the CAPRISA 004 trial, 
however, can take less than an hour to completely coat the vaginal epithelium.
50
 
There are multiple explanations for this history overall, in which health was the directing goal, but was too 
underdetermined to provide direction to the diverse group of actors. One explanation is the compartmentalization of 
research: there is a lack of communication between different research disciplines within universities and the small 
companies engaged in microbicide development. A second is that a lot must be taken into account, tested and 
communicated at each step in the design of a product: the biophysical features of a polymeric gel intrinsically affect 
its effectiveness and have behavioral implications, which ultimately impact user adherence. Third, none of the major 
pharmaceutical companies are involved in microbicide development, as it is not seen as potentially profitable, and 
thus their expertise, which of course would come at a high cost, has not been brought to bear.
51
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Holmberg, in his history of blockages in how the US has dealt with HIV and AIDS, points to the problems of 
mathematical modeling, in which “Reminiscent of the Wizard of Oz's warning ‘Ignore the man behind the curtain,’ 
many of the assumptions…are large, based on scant data and not always clear or even presented to the reader”: 
 
[…] the mathematics can be obtuse and the result predetermined by the assumptions put into the model. Readers of articles in 
general scientific, medical or public health literature will not be able to understand the calculus, other than in a general way, 




We add that a converse corollary is also true: those creating models may not know accurately the limitations of the 
data collected, or have sufficient knowledge about their interaction on the ground to be able to produce meaningful 
quantitative data. There is a need for researchers to develop their capacities, to be given the opportunity to observe, 
participate and iteratively contribute to the development and design of research at multiple levels of a research 
project, such that narrow specialization in one area would be balanced with at least some understanding of the 
research in different parts of the project.
53
 
This relates to research design flaws identified by Padian and colleagues, who in a review of randomized 
controlled trials (RCTs) for HIV prevention found, stunningly, that “almost 90% of RCTs of interventions for 
prevention of sexual transmission of HIV have delivered flat results”.
54
 Some of this failure can be chalked up to 
defective products, such as the early microbicides. However, Padian et al. reported that the majority of the flat 
results were attributable, at least in part, to issues related to trial design and/or implementation.
55
 The difficult work 
of turning ideas into research in the field, especially given the multi-faceted nature of public health, has been done 
without sufficient attention to the operations research aspects of trial implementation, while relatively greater 
attention has been paid to the production of scientific and academic results.  
One of the ways that global health is made to cohere is by the presumption of a shared good–health–and this 
acts as a moral imperative. One question is, what kind of moral imperative is this? Second, how is it turned into 
practices of funding, research, clinical trials, modeling and evaluation? Having discussed the research and 
development of vaginal microbicide gels, we suggest that the regular and explicit gauging what is being counted as 
good, and in what ways, would be a useful tool in global health.  
 
III. Diagnosis  
In this piece we’re dealing with one problem of limited character, but significant effect. The problem of the 
good, part of which is the inability to pose it as a problem, has a capillary relationship to the blockages we describe. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
52 Scott D. Holmberg, Scientific Errors and Controversies in the U.S. HIV/AIDS Epidemic: How They Slowed Advances and Were 
Resolved (Westport, CT and London: Praeger, 2008), 9. 
53 http://www.cugh.org/about/background - ten-recommendations, "Key Needs for the 21st Century: Ten Recommendations from 
the Workforce Sustainability Conference of September 23-25, 2007" (San Francisco, 2007). 
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55 Ibid. 
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Although we are oriented toward reconstruction in practices and institutions in global health, this is neither a 
summary judgment of global health, nor do we suggest that these problems are wholly condemning of this complex 
and heterogeneous assemblage. Rather, there are zones in which problems are going on. These zones have effects 
and should be identified.  
Returning to the call for action by the two anthropologists quoted in the beginning of this piece, they 
passionately ask that scholarship be put to the service of those problems faced by living beings. With this, we are in 
full agreement. The question we pose is, what can that mean? What are the blockages presented by taking health as a 
self-evident, and self-explanatory good? We have identified some in the case study of HIV prevention. The under-
determination of “health” can obscure what may be competing agendas among those providing services, or the needs 
of different populations. Health can be used to justify projects that deserve greater scrutiny, or at least coordination, 
as in the case of competing microbicide trials testing similar products. These are blockages identifiable within global 
health as a system or assemblage; there are others from the position of the subject. Of these, we mention the pursuit 
of a profession, and a vocation. 
People who have dedicated their lives to providing health care have grappled with the problems that arise in 
domestic or international public health, advocacy or medical research in real and significant ways; much work has 
surely been vocational. It is also the case that pragmatic rewards in global health may be quite great, including good 
salary, flexible work conditions, paid travel, and intellectual gratification. Some people work in global health for 
these reasons, or also for these reasons. In parallel, global health is touted as a felicitous combination that generates 
both money and health: doing good is good business.
56
 What is problematic in this is the foreclosure of inquiry into 
what kinds of the goods these may be, and what the ethical practices for pursuing them are, as well as other possible 
forms of good. The two we will discuss briefly are practices of self-care and the fulfillment of curiosity.  
Individuals want to “do global health” for a mix of reasons. The fact that there is almost certainly need at 
home is well-known. But global health is more exotic than local health: the unknown is exciting, challenging oneself 
is rewarding. The element of self-formation and self-care is not incidental nor is it usefully collapsed into care for 
others; we cannot care for others if we don’t care for ourselves.
57
 What is more, those who go on in global health to 
“propose and engage directly in potential solutions” will be confronted with the need to make decisions for which 
the simple equation of health and good will be evidently inadequate. 
 
Regarding scientific curiosity, Holmberg, who spent nearly 20 years in the CDC’s Division of HIV/AIDS 
Prevention, wrote,  
 
Most scientists do science because, as for mountain climbers, the mountain beckons. Unlike mountain climbers, however, they can 
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The pursuit of curiosity, which may sustain the scientist when the potential benefits to health are too distant or 
intangible, is also its own virtue. 
 Stating that health is a good, implicitly assuming it requires no further explanation, and that per se it can serve 
as an actual modus operandi, lays the foundations of a problem: it shuts down inquiry into what practices might 
actually ameliorate the current situation, and what capacities we need to develop or intensify in order to do so. In 
view of the blockages we have described, we ask the question of what could be done in order for reconstructive 
practices to become possible in global health.
59
 If we refuse a choice between global health research as technical 
work in the name of the urgency of health, wealth and security, or a subordinate commitment to what are presumed 
to be self-evident problems of social justice or health disparities, what is left?
60
 
We move instead towards practices that “test of reality, of contemporary reality, both to grasp the points where 
change is possible and desirable, and to determine the precise form this change should take.”
61
 We propose, as a step 
towards creating the conditions under which global health could be reconstructed,
62
 to take up problematization as a 
practice,
63
 around a series of questions to be asked in conjunction with those ever-urgent ones of how to ameliorate 
the condition of living beings. If producing health is our goal, then our questions must include: Is that what our 
practices are doing? What do our actions leave out? What needs to be in place in order to make it happen?
64
 And, 
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